WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2006114019) POLYSACCHARIDE EXTRACT FROM LYCIUM BARBARUM AS NEUROPROTECTIVE AGENT AGAINST BETA-AMYLOID PEPTIDE NEUROTOXICITY
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2006/114019    International Application No.:    PCT/CN2005/000576
Publication Date: 02.11.2006 International Filing Date: 26.04.2005
Chapter 2 Demand Filed:    11.09.2006    
IPC:
A61K 31/715 (2006.01), A61K 36/81 (2006.01), A61K 36/815 (2006.01), C08B 37/00 (2006.01), A61P 9/10 (2006.01)
Applicants: VERSITECH LIMITED [CN/CN]; Finance Office, The University of Hong Kong, Pokfulam Road, Hong Kong (CN) (For All Designated States Except US)
Inventors: CHANG, Chuenchung, Raymond; (CN).
YUEN, Waihung; (CN).
SO, Kwokfai; (CN).
ZEE, S., Y.; (CN)
Agent: CHINA PATENT AGENT (H.K.) LTD.; 22/F, Great Eagle Centre, 23 Harbour Road, Wanchai, Hong Kong (CN)
Priority Data:
Title (EN) POLYSACCHARIDE EXTRACT FROM LYCIUM BARBARUM AS NEUROPROTECTIVE AGENT AGAINST BETA-AMYLOID PEPTIDE NEUROTOXICITY
(FR) EXTRAIT DE POLYSACCHARIDE A PARTIR DE LYCIUM BARBARUM COMME AGENT NEUROPROTECTEUR CONTRE LA NEUROTOXICITE DU PEPTIDE BETA-AMYLOIDE
Abstract: front page image
(EN)Extracts of Lycium barbarum serve as a neuroprotective agent against ß-amyloid peptide neurotoxicity which thus permits their use for the treatment of Alzheimer's disease (AD) and for the prevention of neuronal loss in aging against the accumulation of ß-amyloid peptide in the brain. Stress kinases (c-Jun N-terminal kinase and dour e-stranded RNA-dependent protein kinase) are used as a technological platform for screening neuroprotective drugs.
(FR)La présente invention a trait à des extraits de Lycium barbarum comme agent neuroprotecteur contre la neurotoxicité du peptide $g(b)-amyloïde permettant ainsi leur utilisation pour le traitement de la maladie d'Alzheimer et pour la prévention de la perte neuronale en vieillissant contre l'accumulation du peptide $g(b)-amyloïde dans le cerveau. Des stress kinases (la c-Jun N-terminal kinase et la protéine kinase dépendante d'ARN bicaténaire) sont utilisées comme plate-forme technologique pour le criblage de médicaments neuroprotecteurs.
Designated States: AE, AG, AL, AM, AT, AU, AZ, BA, BB, BG, BR, BW, BY, BZ, CA, CH, CN, CO, CR, CU, CZ, DE, DK, DM, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KP, KR, KZ, LC, LK, LR, LS, LT, LU, LV, MA, MD, MG, MK, MN, MW, MX, MZ, NA, NI, NO, NZ, OM, PG, PH, PL, PT, RO, RU, SC, SD, SE, SG, SK, SL, SM, SY, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, YU, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HU, IE, IS, IT, LT, LU, MC, NL, PL, PT, RO, SE, SI, SK, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)